Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Sixteen-Week, Double-Blind, Placebo-Controlled, Trial of Seroquel in Combination With Treatment as Usual in Patients With GAD and Remitted Comorbid Opiate Dependence

NCT00668265 is registered in ClinicalTrials.gov with Beth Israel Medical Center as lead sponsor.

NCT NCT00668265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00668265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Sixteen-Week, Double-Blind, Placebo-Controlled, Trial of Seroquel in Combination With Treatment as Usual in Patients With GAD and Remitted Comorbid Opiate Dependence
Lead sponsor
Beth Israel Medical Center
Phase
Phase 4
Overall status
Terminated
Start date
January 31, 2008
Completion date
August 31, 2011
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

comorbid opiate dependence in remission, generalized anxiety disorder, status post methadone-maintenance treatment